Literature DB >> 23860128

A miR-34a-SIRT6 axis in the squamous cell differentiation network.

Karine Lefort1, Yang Brooks, Paola Ostano, Muriel Cario-André, Valérie Calpini, Juan Guinea-Viniegra, Andrea Albinger-Hegyi, Wolfram Hoetzenecker, Ingrid Kolfschoten, Erwin F Wagner, Sabine Werner, Gian Paolo Dotto.   

Abstract

Squamous cell carcinomas (SCCs) are highly heterogeneous tumours, resulting from deranged expression of genes involved in squamous cell differentiation. Here we report that microRNA-34a (miR-34a) functions as a novel node in the squamous cell differentiation network, with SIRT6 as a critical target. miR-34a expression increases with keratinocyte differentiation, while it is suppressed in skin and oral SCCs, SCC cell lines, and aberrantly differentiating primary human keratinocytes (HKCs). Expression of this miRNA is restored in SCC cells, in parallel with differentiation, by reversion of genomic DNA methylation or wild-type p53 expression. In normal HKCs, the pro-differentiation effects of increased p53 activity or UVB exposure are miR-34a-dependent, and increased miR-34a levels are sufficient to induce differentiation of these cells both in vitro and in vivo. SIRT6, a sirtuin family member not previously connected with miR-34a function, is a direct target of this miRNA in HKCs, and SIRT6 down-modulation is sufficient to reproduce the miR-34a pro-differentiation effects. The findings are of likely biological significance, as SIRT6 is oppositely expressed to miR-34a in normal keratinocytes and keratinocyte-derived tumours.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23860128      PMCID: PMC3746195          DOI: 10.1038/emboj.2013.156

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  95 in total

1.  Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs.

Authors:  Christopher K Raymond; Brian S Roberts; Phillip Garrett-Engele; Lee P Lim; Jason M Johnson
Journal:  RNA       Date:  2005-11       Impact factor: 4.942

2.  Genomic instability and aging-like phenotype in the absence of mammalian SIRT6.

Authors:  Raul Mostoslavsky; Katrin F Chua; David B Lombard; Wendy W Pang; Miriam R Fischer; Lionel Gellon; Pingfang Liu; Gustavo Mostoslavsky; Sonia Franco; Michael M Murphy; Kevin D Mills; Parin Patel; Joyce T Hsu; Andrew L Hong; Ethan Ford; Hwei-Ling Cheng; Caitlin Kennedy; Nomeli Nunez; Roderick Bronson; David Frendewey; Wojtek Auerbach; David Valenzuela; Margaret Karow; Michael O Hottiger; Stephen Hursting; J Carl Barrett; Leonard Guarente; Richard Mulligan; Bruce Demple; George D Yancopoulos; Frederick W Alt
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

3.  Specific microRNAs are preferentially expressed by skin stem cells to balance self-renewal and early lineage commitment.

Authors:  Liang Zhang; Nicole Stokes; Lisa Polak; Elaine Fuchs
Journal:  Cell Stem Cell       Date:  2011-03-04       Impact factor: 24.633

4.  Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1.

Authors:  Na Li; Senthilkumar Muthusamy; Ruqiang Liang; Harshini Sarojini; Eugenia Wang
Journal:  Mech Ageing Dev       Date:  2011-01-07       Impact factor: 5.432

5.  The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo.

Authors:  Kristen L Meerbrey; Guang Hu; Jessica D Kessler; Kevin Roarty; Mamie Z Li; Justin E Fang; Jason I Herschkowitz; Anna E Burrows; Alberto Ciccia; Tingting Sun; Earlene M Schmitt; Ronald J Bernardi; Xiaoyong Fu; Christopher S Bland; Thomas A Cooper; Rachel Schiff; Jeffrey M Rosen; Thomas F Westbrook; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-09       Impact factor: 11.205

Review 6.  Crosstalk of Notch with p53 and p63 in cancer growth control.

Authors:  G Paolo Dotto
Journal:  Nat Rev Cancer       Date:  2009-07-16       Impact factor: 60.716

7.  EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer.

Authors:  Vihren Kolev; Anna Mandinova; Juan Guinea-Viniegra; Bing Hu; Karine Lefort; Chiara Lambertini; Victor Neel; Reinhard Dummer; Erwin F Wagner; G Paolo Dotto
Journal:  Nat Cell Biol       Date:  2008-07-06       Impact factor: 28.824

Review 8.  Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression.

Authors:  Karine Lefort; G Paolo Dotto
Journal:  Semin Cancer Biol       Date:  2004-10       Impact factor: 15.707

9.  Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases.

Authors:  Karine Lefort; Anna Mandinova; Paola Ostano; Vihren Kolev; Valerie Calpini; Ingrid Kolfschoten; Vikram Devgan; Jocelyn Lieb; Wassim Raffoul; Daniel Hohl; Victor Neel; Jonathan Garlick; Giovanna Chiorino; G Paolo Dotto
Journal:  Genes Dev       Date:  2007-03-01       Impact factor: 11.361

10.  IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes.

Authors:  Gaetana Restivo; Bach-Cuc Nguyen; Piotr Dziunycz; Elodie Ristorcelli; Russell J H Ryan; Özden Yalçin Özuysal; Matteo Di Piazza; Freddy Radtke; Michael J Dixon; Günther F L Hofbauer; Karine Lefort; G Paolo Dotto
Journal:  EMBO J       Date:  2011-11-16       Impact factor: 11.598

View more
  61 in total

1.  SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in mice.

Authors:  Pamela Becherini; Irene Caffa; Francesco Piacente; Patrizia Damonte; Valerio G Vellone; Mario Passalacqua; Andrea Benzi; Tommaso Bonfiglio; Daniele Reverberi; Amr Khalifa; Moustafa Ghanem; Ana Guijarro; Luca Tagliafico; Marzia Sucameli; Angelica Persia; Fiammetta Monacelli; Michele Cea; Santina Bruzzone; Silvia Ravera; Alessio Nencioni
Journal:  Cancer Metab       Date:  2021-01-22

Review 2.  SIRT6, a Mammalian Deacylase with Multitasking Abilities.

Authors:  Andrew R Chang; Christina M Ferrer; Raul Mostoslavsky
Journal:  Physiol Rev       Date:  2019-08-22       Impact factor: 37.312

3.  A crucial role of SUMOylation in modulating Sirt6 deacetylation of H3 at lysine 56 and its tumor suppressive activity.

Authors:  J Cai; Y Zuo; T Wang; Y Cao; R Cai; F-L Chen; J Cheng; J Mu
Journal:  Oncogene       Date:  2016-02-22       Impact factor: 9.867

Review 4.  The sirtuin 6: An overture in skin cancer.

Authors:  Liz M Garcia-Peterson; Glorimar Guzmán-Pérez; Cassandre R Krier; Nihal Ahmad
Journal:  Exp Dermatol       Date:  2019-12-29       Impact factor: 3.960

Review 5.  An updated review of mechanotransduction in skin disorders: transcriptional regulators, ion channels, and microRNAs.

Authors:  Jing Wang; Yifan Zhang; Ning Zhang; Chuandong Wang; Tanja Herrler; Qingfeng Li
Journal:  Cell Mol Life Sci       Date:  2015-02-15       Impact factor: 9.261

6.  The role of SIRT6 in tumors.

Authors:  Vanessa Desantis; Aurelia Lamanuzzi; Angelo Vacca
Journal:  Haematologica       Date:  2018-01       Impact factor: 9.941

7.  miR-34a inhibits tumorigenesis of NSCLC via targeting SIRT6.

Authors:  Libo Ruan; Jun Chen; Litao Ruan; Anjun Tan; Ping Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

8.  Inhibition of Sirt6 suppresses tumor growth by inducing G1/S phase arrest in renal cancer cells.

Authors:  Yu Ding; Sisi Wu; Yuwei Huo; Xuemei Chen; Li Chai; Yan Wang; Xiangxiu Wang; Guonian Zhu; Wei Jiang
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

9.  Age-related epigenetic drift deregulates SIRT6 expression and affects its downstream genes in human peripheral blood mononuclear cells.

Authors:  Magdalena Owczarz; Jacek Połosak; Anna Domaszewska-Szostek; Paulina Kołodziej; Alina Kuryłowicz; Monika Puzianowska-Kuźnicka
Journal:  Epigenetics       Date:  2020-06-23       Impact factor: 4.528

10.  Multifactorial ERβ and NOTCH1 control of squamous differentiation and cancer.

Authors:  Yang Sui Brooks; Paola Ostano; Seung-Hee Jo; Jun Dai; Spiro Getsios; Piotr Dziunycz; Günther F L Hofbauer; Kara Cerveny; Giovanna Chiorino; Karine Lefort; G Paolo Dotto
Journal:  J Clin Invest       Date:  2014-04-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.